Stockreport

FDA Decisions Put Johnson & Johnson's Growth And Valuation In Focus [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF FDA grants Priority Review for Johnson & Johnson's IMAAVY (nipocalimab) in warm autoimmune hemolytic anemia, the first therapy in this rare blood disorder to receive th [Read more]